News Conference News ESC 2022 Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration Michael O'Riordan August 29, 2022
News Conference News ESC 2022 Polypill Bests Usual Care in Patients With Recent MI: SECURE Michael O'Riordan August 26, 2022
News Conference News ESC 2021 New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy Michael O'Riordan September 03, 2021
News Conference News ESC 2021 No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER Michael O'Riordan September 02, 2021
News Conference News ESC 2021 Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention Michael O'Riordan August 31, 2021
News Conference News ESC 2019 New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises Michael O'Riordan September 04, 2019
News Conference News ESC 2019 Lifelong Exposure to Lower LDL and BP Linked With Big Reduction in CVD Events Michael O'Riordan September 02, 2019
News Conference News ESC 2019 Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4 Michael O'Riordan September 02, 2019
News Conference News ESC 2018 Redefined ‘High-Quality’ Diet Lowers Risk of All-Cause Mortality: PURE Michael O'Riordan August 28, 2018
News Conference News ESC 2018 Sobering News From Europe: CVD Risk Factors Are on the Rise or Holding Firm Todd Neale August 27, 2018